EMD Millipore May 5, 2014, Billerica, MA — EMD Millipore, the life science division of Merck KGaA of Darmstadt, Germany, today announces the expansion of its upstream services into North America as part of its Provantage® Biodevelopment and Clinical Supply offering. The company’s Massachusetts facilities will now offer upstream capabilities including media and feed screening, small-scale material production, and optimization of conditions for scale-up and technology transfer. This expansion allows EMD Millipore’s North American customers to access the same services…